当前位置:首页 - 行情中心 - 百洋医药(301015) - 财务分析

百洋医药

(301015)

  

流通市值:98.28亿  总市值:98.29亿
流通股本:5.26亿   总股本:5.26亿

百洋医药(301015)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年第一季度实现净利润1.10亿元,每股收益0.16元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年第一季度最新股东权益271394.25万元,未分配利润163331.88万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年第一季度最新总资产730289.79万元,负债458895.54万元。

利润表
报告期2025-03-312024-12-312024-09-302024-06-30
营业总收入1,840,874,860.518,094,458,068.746,143,923,658.273,594,708,467.52
营业总成本1,635,496,471.037,169,337,235.285,252,717,606.613,123,535,308.65
营业利润145,211,340.24977,737,964.01911,469,828.6477,052,032.77
利润总额143,254,109.6966,627,616.78907,916,950.83474,485,081.15
净利润109,662,899.99767,030,644.39690,576,353.68366,041,224.32
其他综合收益628,024.82-104,993.07-1,596,916.54-1,140,551.27
综合收益总额110,290,924.81766,925,651.32688,979,437.14364,900,673.05
资产负债表
报告期2025-03-312024-12-312024-09-302024-06-30
流动资产合计5,216,481,448.145,110,975,480.55,370,923,485.575,148,586,920.69
非流动资产合计2,086,416,459.582,001,608,770.631,525,464,674.47906,658,549.15
资产总计7,302,897,907.727,112,584,251.136,896,388,160.046,055,245,469.84
流动负债合计3,354,576,985.413,257,963,613.643,135,223,401.292,591,704,196.14
非流动负债合计1,234,378,391.871,249,949,031.861,245,966,171.11856,825,773.35
负债合计4,588,955,377.284,507,912,645.54,381,189,572.43,448,529,969.49
归属于母公司股东权益合计2,460,493,402.782,374,910,404.592,310,358,153.992,635,517,392.51
股东权益合计2,713,942,530.442,604,671,605.632,515,198,587.642,606,715,500.35
负债和股东权益合计7,302,897,907.727,112,584,251.136,896,388,160.046,055,245,469.84
现金流量表
报告期2025-03-312024-12-312024-09-302024-06-30
经营活动现金流入小计2,106,729,811.898,764,150,968.686,429,999,941.743,887,894,668.38
经营活动现金流出小计1,806,739,127.87,950,300,563.795,867,575,703.113,538,794,795.38
经营活动产生的现金流量净额299,990,684.09813,850,404.89562,424,238.63349,099,873
投资活动现金流入小计50,153,288.52398,660,782.45257,954,800.8310,453,180.81
投资活动现金流出小计252,012,575.921,130,979,506.36768,391,595.969,249,979.51
投资活动产生的现金流量净额-201,859,287.4-732,318,723.91-510,436,795.07-58,796,798.7
筹资活动现金流入小计711,385,385.492,199,793,250.951,719,270,694.021,193,975,762.41
筹资活动现金流出小计446,144,717.862,195,127,583.981,863,582,921.13764,343,678.42
筹资活动产生的现金流量净额265,240,667.634,665,666.97-144,312,227.11429,632,083.99
汇率变动对现金及现金等价物的影响-1,701,430.832,205,432.12-3,864,924.45641,303.03
现金及现金等价物净增加额361,670,633.4988,402,780.07-96,189,708720,576,461.32
期末现金及现金等价物余额1,584,216,827.541,222,546,194.051,037,953,705.981,711,176,331.32
最新报告期:2025-05-13
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
西南证券杜向阳1.501.691.932025-05-13
华源证券刘闯1.451.712.042025-04-28
浙商证券王帅,胡隽扬1.421.671.932025-04-28
开源证券余汝意,巢舒然1.441.742.152025-04-25
东方证券伍云飞1.451.651.892025-04-25
TOP↑